z-logo
open-access-imgOpen Access
Treatment of intramural ventricular tachycardia in cardiac sarcoidosis with transcoronary ethanol ablation
Author(s) -
Steven M. Markowitz,
Robert M. Minutello,
Luke K. Kim,
James E. Ip,
George Thomas,
Bruce B. Lerman
Publication year - 2017
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/eux277
Subject(s) - medicine , cardiac sarcoidosis , cardiology , ablation , ventricular tachycardia , tachycardia , sarcoidosis
The patient is a 67-year-old man who had recurrent ventricular tachycardia (VT) despite treatment with amiodarone. Cardiac magnetic resonance imaging (MRI) demonstrated delayed enhancement of the mid-myocardium in the basal inferolateral wall and septum (Figure, Panel A). Cardiac Positron emission tomography–computed tomography (PET–CT) showed a perfusion defect with increased 18F-fluorodeoxyglucose uptake in the inferolateral wall, consistent with active myocardial inflammation. During electrophysiologic study, two different VT morphologies were induced, with left bundle branch block and right bundle branch block, left superior axes, respectively (Figure, Panels B and C). The VT cycle lengths were 330–400 ms. The earliest activation during VT (35 ms pre-QRS) and the best pace and entrainment maps were at the cardiac crux along the inferior interventricular septum near the posterior descending artery. The patient underwent four attempts at radiofrequency (RF) catheter ablation, including epicardial ablation, and bipolar transmural RF ablation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom